58. 肥大型心筋症 Hypertrophic cardiomyopathy Clinical trials / Disease details

臨床試験数 : 126 / 薬物数 : 135 - (DrugBank : 42) / 標的遺伝子数 : 46 - 標的パスウェイ数 : 162

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04133532 (ClinicalTrials.gov)	March 5, 2020	16/10/2019	Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy	Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy	Hypertrophic Cardiomyopathy	Drug: Metoprolol	University Hospital, Motol	NULL	Recruiting	18 Years	75 Years	All	50	Phase 4	Czechia
2	NCT03532802 (ClinicalTrials.gov)	May 1, 2018	19/4/2018	The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy.	The Effect of Metoprololon Myocardial Function, Perfusion, Hemodynamics and Heart Failure Symptoms i ...	Hypertrophic Cardiomyopathy	Drug: Metoprolol Succinate;Drug: Placebo oral capsule	Steen Hvitfeldt Poulsen	NULL	Completed	18 Years	N/A	All	30	Phase 2	Denmark
3	EUCTR2017-004478-32-DK (EUCTR)	10/01/2018	14/12/2017	The effect of metoprolol in hypertrophic obstructive cardiomyopathy	The effect of metoprololon myocardial function, hemodynamics and heart failure symptoms in patients ...	Hypertrophic obstructive cardiomyopathy MedDRA version: 20.0;Level: LLT;Classification code 10020876 ...	Trade Name: Metoprololsuccinat INN or Proposed INN: metoprololsuccinat Other descriptive name: METOPRO ...	Aarhus University Hospital	NULL	Not Recruiting			Female: yes Male: yes	32	Phase 2	Denmark

First Previous1Next Last